Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02118766 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 763
- Enrollment target
NCT02118766 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 763 participants.
The verdict
NCT02118766, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 763 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the safety and efficacy of AN2728 Topical Ointment, 2% in children, adolescents, and adults (ages 2 years and older) with atopic dermatitis.
Interventions
- DRUG AN2728 Topical Ointment, 2%
- DRUG Matching vehicle control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 763 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02118766
The ClinicalTrials.gov registry entry for NCT02118766 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 763 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AN2728 Topical Ointment, 2% is the first listed.
NCT02118766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02118766 about?
NCT02118766 is a clinical study titled "Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis". The purpose of this study is to investigate the safety and efficacy of AN2728 Topical Ointment, 2% in children, adolescents, and adults (ages 2 years and older) with atopic dermatitis.
What is the current status of trial NCT02118766?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 763 participants. The study started on 2014-03. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02118766?
The interventions under investigation include: AN2728 Topical Ointment, 2% (DRUG), Matching vehicle control (DRUG).
Who is sponsoring clinical trial NCT02118766?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.